Clinical and Translational Science (Jul 2020)

Hydroxychloroquine for Treatment of SARS‐CoV‐2 Infection? Improving Our Confidence in a Model‐Based Approach to Dose Selection

Samuel L.M. Arnold,
Frederick Buckner

Affiliations

Samuel L.M. Arnold: Center for Emerging and Reemerging Infectious Diseases (CERID) University of Washington Seattle Washington USA
Frederick Buckner: Center for Emerging and Reemerging Infectious Diseases (CERID) University of Washington Seattle Washington USA

DOI: https://doi.org/10.1111/cts.12797
Journal volume & issue: Vol. 13, no. 4
pp. 642 – 645

Abstract

No abstracts available.

Published in Clinical and Translational Science

ISSN: 1752-8054 (Print); 1752-8062 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Therapeutics. Pharmacology; Medicine: Public aspects of medicine
Website: https://ascpt.onlinelibrary.wiley.com/journal/17528062

About the journal